SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-03-025142
Filing Date
2003-11-07
Accepted
2003-11-07 16:35:15
Documents
8
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a03-4987_110q.htm 10-Q 648742
3 EX-10.195 a03-4987_1ex10d195.htm EX-10.195 144085
4 EX-10.26.3 a03-4987_1ex10d26d3.htm EX-10.26.3 19192
5 EX-31.1 a03-4987_1ex31d1.htm EX-31.1 10474
6 EX-31.2 a03-4987_1ex31d2.htm EX-31.2 10512
7 EX-31.3 a03-4987_1ex31d3.htm EX-31.3 10499
8 EX-31.4 a03-4987_1ex31d4.htm EX-31.4 10461
9 EX-32 a03-4987_1ex32.htm EX-32 7456
  Complete submission text file 0001104659-03-025142.txt   863727
Mailing Address 35 W WATKINS MILL ROAD GAITHERSBURG MD 20878
Business Address 35 W WATKINS MILL RD GAITHERSBURG MD 20878 3014170770
MEDIMMUNE INC /DE (Filer) CIK: 0000873591 (see all company filings)

IRS No.: 521555759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14657 | Film No.: 03985642
SIC: 2836 Biological Products, (No Diagnostic Substances)